Ypsomed injects CHF200 million to gain a foothold in the US

Published on October 10, 2025

See on Internet Archive

by
Swissinfo
My articles My site About me My videos My books
Follow on:Twitter Facebook Google +

Self-injection device manufacturer Ypsomed is planning to build its first factory in the United States. It has set its sights on the Holly Springs site in North Carolina, where it plans to invest an initial CHF200 million ($248 million). The plant is due to start supplying US demand at the end of 2027, according to a press release issued on Friday. When it comes on stream, the plant is expected to create around a hundred jobs, a figure that Ypsomed already expects to double over the next few years. +Get the most important news from Switzerland in your inbox Management reiterates that it has adopted a strategy of all-out growth, with the recent opening of a production site in China, the launch of a project to expand its capacity in Schwerin, Germany, worth "several hundred million Swiss francs", and the expansion of its capacity in Solothurn, worth around 200 million Swiss francs. At the beginning of August, Chief Executive Officer (CEO) Simon Michel articulated a total investment ... Full story here Are you the author?

About Swissinfo

SWI swissinfo.ch – the international service of the Swiss Broadcasting Corporation (SBC). Since 1999, swissinfo.ch has fulfilled the federal government’s mandate to distribute information about Switzerland internationally, supplementing the online offerings of the radio and television stations of the SBC. Today, the international service is directed above all at an international audience interested in Switzerland, as well as at Swiss citizens living abroad.

My articles My site About me My books
Follow on:Twitter Facebook Google +